Contineum Therapeutics (CTNM) EPS (Basic) (2023 - 2024)
Historic EPS (Basic) for Contineum Therapeutics (CTNM) over the last 2 years, with Q4 2024 value amounting to -$0.57.
- Contineum Therapeutics' EPS (Basic) fell 754.72% to -$0.57 in Q4 2024 from the same period last year, while for Sep 2025 it was -$0.52, marking a year-over-year increase of 6241.27%. This contributed to the annual value of -$2.18 for FY2024, which is 26029.41% down from last year.
- Latest data reveals that Contineum Therapeutics reported EPS (Basic) of -$0.57 as of Q4 2024, which was down 754.72% from -$0.4 recorded in Q3 2024.
- Contineum Therapeutics' EPS (Basic)'s 5-year high stood at $2.56 during Q2 2023, with a 5-year trough of -$3.55 in Q1 2024.